microenvironments affects their expansion capacity and their response to ruxolitinib treatment. 6Thus, an in vitro model that recreates these microenvironments in a humanized context would enable detailed studies of their underlying cross talk and help identify therapeutic vulnerabilities.
Mattias Carlsten (Thu,) studied this question.